Related Experiment Video
Updated: Apr 6, 2026

07:34
FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
38.1K
Fetal Cell Based Prenatal Diagnosis: Perspectives on the Present and Future
1DePaul University and Insight Medical Genetics, LLC 680 N, Lake Shore Drive Chicago, IL 60611, USA. mfiddler@insightmedicalgenetics.com.
Journal of Clinical Medicine
|August 4, 2015
Summary
Capturing fetal cells non-invasively for prenatal diagnostics remains a challenge. Recent advances in cell-free DNA screening have raised the bar for fetal cell-based methods, driving continued research.
Area of Science:
- Reproductive biology
- Genetics
- Medical diagnostics
Background:
- Non-invasive prenatal diagnosis (NIPD) aims to replace invasive procedures by analyzing fetal material from maternal circulation.
- For over 30 years, isolating and analyzing fetal cells has been a key goal for NIPD, offering comprehensive genomic insights.
- Despite significant innovation, a reliable method for fetal cell capture and analysis remains elusive.
Purpose of the Study:
- To review the historical progress and current state of fetal cell-based non-invasive prenatal diagnostics.
- To examine the challenges and ongoing investigations in capturing and analyzing fetal cells from maternal sources.
- To contextualize fetal cell-based approaches in light of advancements in cell-free DNA screening.
Main Methods:
- Historical review of research and development in fetal cell isolation techniques.
- Analysis of current investigative strategies for fetal cell capture and molecular analysis.
- Comparison of fetal cell-based methods with emerging cell-free DNA screening technologies.
Main Results:
- The complete isolation and reliable analysis of fetal cells from maternal circulation for NIPD has not yet been achieved.
- The development of cell-free DNA screening has established new benchmarks for accuracy and utility in prenatal testing.
- Ongoing research continues to explore novel methods for enhancing fetal cell recovery and characterization.
Conclusions:
- The pursuit of non-invasive prenatal diagnosis via fetal cell analysis persists, despite persistent technical hurdles.
- The field of NIPD is evolving, with cell-free DNA screening setting new standards for clinical application.
- Continued innovation is necessary to develop accessible and dependable strategies for fetal cell-based prenatal diagnostics.

